Oran D Kennedy

Summary

Affiliation: City University of New York
Country: USA

Publications

  1. pmc Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations
    Oran D Kennedy
    Department of Biomedical Engineering, The City College of New York, New York, NY 10031, USA
    Bone 50:1115-22. 2012
  2. pmc Osteocyte signaling in bone
    Mitchell B Schaffler
    New York Center for Biomedical Engineering, City College of New York, 160 Convent Avenue, New York, NY, 10031, USA
    Curr Osteoporos Rep 10:118-25. 2012
  3. doi request reprint Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor
    Yingjie Wu
    David B Kriser Dental Center, Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, NY, USA
    J Bone Miner Res 28:1575-86. 2013

Collaborators

  • Shoshana Yakar
  • Luis Cardoso
  • Mitchell B Schaffler
  • Yingjie Wu
  • Horacio Domene
  • Hui Sun
  • Hector Jasper
  • Clara Guida
  • Clifford J Rosen
  • Jelena Basta-Pljakic
  • Liliana Karabatas

Detail Information

Publications3

  1. pmc Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations
    Oran D Kennedy
    Department of Biomedical Engineering, The City College of New York, New York, NY 10031, USA
    Bone 50:1115-22. 2012
    ..Moreover, both the apoptotic and osteoclast-signaling osteocyte populations are localized in a spatially and temporally restricted pattern consistent with the targeted nature of this remodeling response...
  2. pmc Osteocyte signaling in bone
    Mitchell B Schaffler
    New York Center for Biomedical Engineering, City College of New York, 160 Convent Avenue, New York, NY, 10031, USA
    Curr Osteoporos Rep 10:118-25. 2012
    ..Osteocytes appear to be the major local orchestrator of many of bone's functions...
  3. doi request reprint Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor
    Yingjie Wu
    David B Kriser Dental Center, Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, NY, USA
    J Bone Miner Res 28:1575-86. 2013
    ..These findings are consistent with clinical data showing that IGF-I replacement therapy in patients with Laron syndrome does not achieve full skeletal growth...